Sherwin-Williams reported extraordinary 268% revenue growth from $4.9B to $17.9B, indicating a major acquisition or business combination.
This massive revenue increase far exceeds organic growth possibilities and likely represents a transformational acquisition that has fundamentally changed the company's scale and operations. The disproportionate operating income growth of only 23% versus 268% revenue growth suggests integration costs or lower-margin business acquisition that investors should scrutinize carefully.
The financial results show a company that has undergone massive transformation, with revenue exploding 268% to $17.9B while operating income grew a more modest 23% to $4.2B, indicating significant margin compression from the new operations. Balance sheet strength improved with stockholders' equity up 13.5% and current assets growing 11.2%, while increased capex of 37% and higher accounts receivable suggest investment in the expanded business infrastructure. The overall picture signals a major acquisition that has dramatically increased scale but potentially at the cost of profitability margins.
Strong top-line growth of 267.7% — accelerating demand or successful expansion into new markets.
Capital expenditure jumped 37% — major investment cycle underway; assess returns on deployment.
Operating income improving — cost discipline or growing revenue base absorbing fixed costs.
Receivables grew 16.8% — monitor days sales outstanding for collection efficiency.
Equity base grew 13.5% — retained earnings accumulation or equity issuance strengthening the balance sheet.
R&D spending cut 11.2% — could signal cost discipline or concerning reduction in innovation investment.
Current assets grew 11.2% — improving short-term liquidity or inventory/receivables build.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →